INVIVO THERAPEUTICS HLDGS CO (NVIV)
Institutional ownership reported to the SEC as of Q4 2019, across 5 quarters.
11
Reporting holders
$484.0K
Reported value
0.0%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | $253.0K | 1,125,000 | 0.23% | new | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $166.0K | 736,572 | 0.00% | 5q | +53.0%+$57.5K |
| VANGUARD GROUP INC | $19.0K | 85,892 | 0.00% | 5q | HELD |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10.0K | 43,039 | 0.00% | new | NEW |
| UBS Group AG | $10.0K | 44,624 | 0.00% | 2q | +231.8%+$7.0K |
| CITADEL ADVISORS LLC | $9.0K | 41,191 | 0.00% | new | NEW |
| IMS Capital Management | $5.0K | 23,472 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $4.0K | 20,072 | 0.00% | 5q | +100.0%+$2.0K |
| BlackRock Inc. | $4.0K | 19,446 | 0.00% | 5q | HELD |
| NORTHERN TRUST CORP | $3.0K | 15,037 | 0.00% | 5q | HELD |
| MORGAN STANLEY | $1.0K | 3,395 | 0.00% | 7q | -1.2% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2019 | 11 | $484.0K | 2,157,740 | 4 | 3 | 1 | 0.0% |
| Q3 2019 | 10 | $337.0K | 666,037 | 1 | 1 | 1 | 0.0% |
| Q2 2019 | 15 | $513.0K | 693,747 | 2 | 2 | 2 | 0.0% |
| Q1 2019 | 17 | $1.1M | 689,889 | 2 | 3 | 6 | 0.0% |
| Q4 2018 | 16 | $1.1M | 767,704 | 0 | 0 | 1 | 0.0% |